STERIS SVP receives new stock and option awards

STERIS plc senior executive Cary L. Majors reported routine equity compensation and related tax withholding.

Rhea-AI Filing Summary

STERIS plc senior executive Cary L. Majors reported routine equity compensation and related tax withholding. On June 2, 2026, he received a grant of 4,746 ordinary shares, bringing his direct holdings to 17,405 shares. A separate entry shows 67 shares disposed at $209.76 per share solely to satisfy tax obligations on 2,140 restricted shares that vested the same day.

Majors was also granted an employee stock option for 16,548 ordinary shares at an exercise price of $230.74 per share, expiring on June 2, 2036. As of June 2, 2026, 10,047 of his ordinary shares are restricted, scheduled to vest in stages through June 4, 2029. In addition, units representing 67 ordinary share equivalents are held for him under the STERIS Corporation 401(k) Plan.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Majors Cary L

Role SVP and President, Healthcare

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	16,548	$0.00	$0.00
Grant/Award	Ordinary Shares	4,746	$0.00	$0.00
Exercise Price or Tax Liability	Ordinary Shares	67	$209.76	$14K
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 16,548 contracts (Direct); Ordinary Shares — 17,338 shares (Direct); Ordinary Shares — 67 shares (Indirect, See Footnote Below)

Footnotes (4)

1. F1. As of June 2, 2026, 10,047 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,379 on June 4, 2027; 2,922 on June 5, 2028 and 4,746 on June 4, 2029.
2. F2. 67 shares were withheld from the 2,140 restricted shares that vested on June 2, 2026. These 67 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.
3. F3. Units representing 67 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 29, 2026.
4. F4. This option becomes exercisable as follows: 4,137 on June 2, 2027, 4,137 on June 2, 2028, 4,137 on June 4, 2029 and 4,137 on June 3, 2030.

Key Figures

Share grant: 4,746 ordinary shares Tax-withheld shares: 67 ordinary shares Tax withholding valuation price: $209.76 per share +5 more

8 metrics

Share grant 4,746 ordinary shares Equity award to Cary L. Majors on June 2, 2026

Tax-withheld shares 67 ordinary shares Withheld to cover taxes on 2,140 restricted shares vesting June 2, 2026

Tax withholding valuation price $209.76 per share Value used for 67 shares withheld for taxes

Post-transaction direct holding 17,405 ordinary shares Direct shares held by Cary L. Majors after transactions

Restricted shares outstanding 10,047 ordinary shares Restricted as of June 2, 2026, vesting through June 4, 2029

Stock option grant size 16,548 options Employee stock option covering ordinary shares granted June 2, 2026

Stock option exercise price $230.74 per share Exercise price for 16,548-share employee stock option

Indirect 401(k) units 67 share equivalents Units held under STERIS Corporation 401(k) Plan as of May 29, 2026

Key Terms

restricted, restricted shares that vested, Employee Stock Option (right to buy), 401(k) Plan, +1 more

5 terms

restricted financial

"As of June 2, 2026, 10,047 of these ordinary shares are restricted."

restricted shares that vested financial

"67 shares were withheld from the 2,140 restricted shares that vested on June 2, 2026."

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy) ... underlying security shares 16,548.0000"

401(k) Plan financial

"Units representing 67 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 29, 2026."

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

taxes required to be withheld financial

"These 67 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did STERIS (STE) executive Cary L. Majors report?

Cary L. Majors reported routine equity transactions, including a grant of 4,746 ordinary shares and an employee stock option for 16,548 shares. He also had 67 shares withheld to cover taxes on newly vested restricted stock, with no open-market purchases or sales disclosed.

How many STERIS (STE) shares does Cary L. Majors hold after these Form 4 transactions?

After the reported transactions, Cary L. Majors holds 17,405 ordinary shares directly and 67 ordinary share equivalents indirectly in the STERIS Corporation 401(k) Plan. As of June 2, 2026, 10,047 of his ordinary shares remain restricted and will vest over several future dates.

What equity awards did Cary L. Majors receive from STERIS (STE) on June 2, 2026?

On June 2, 2026, Cary L. Majors received 4,746 ordinary shares as an equity grant and an employee stock option covering 16,548 ordinary shares at an exercise price of $230.74. The option expires on June 2, 2036 and vests in four equal annual installments.

Were any of Cary L. Majors’ STERIS (STE) shares sold on the market in this Form 4?

The filing shows 67 shares disposed at $209.76 per share, but these were withheld by the company to cover tax obligations on 2,140 restricted shares that vested. This represents tax-withholding, not an open-market sale initiated for investment reasons.

How many restricted STERIS (STE) shares does Cary L. Majors have and when do they vest?

As of June 2, 2026, Cary L. Majors holds 10,047 restricted ordinary shares. These restrictions lapse in tranches: 2,379 shares on June 4, 2027; 2,922 shares on June 5, 2028; and 4,746 shares on June 4, 2029, subject to continued eligibility conditions.

What are the key terms of Cary L. Majors’ new STERIS (STE) stock option grant?

The new employee stock option covers 16,548 ordinary shares at an exercise price of $230.74 per share. It becomes exercisable in four installments between June 2, 2027 and June 3, 2030, and expires on June 2, 2036, aligning with a long-term incentive structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Majors Cary L

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and President, Healthcare

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/02/2026		A		4,746	A	$0	17,405(1)	D
Ordinary Shares	06/02/2026		F		67(2)	D	$209.76	17,338(1)	D
Ordinary Shares								67	I	See Footnote Below(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$230.74	06/02/2026		A		16,548		(4)	06/02/2036	Ordinary Shares	16,548	$0	16,548	D

Explanation of Responses:

1. As of June 2, 2026, 10,047 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,379 on June 4, 2027; 2,922 on June 5, 2028 and 4,746 on June 4, 2029.

2. 67 shares were withheld from the 2,140 restricted shares that vested on June 2, 2026. These 67 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.

3. Units representing 67 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 29, 2026.

4. This option becomes exercisable as follows: 4,137 on June 2, 2027, 4,137 on June 2, 2028, 4,137 on June 4, 2029 and 4,137 on June 3, 2030.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)